PL211703A1 - Sposob wytwarzania nowego peptydu - Google Patents

Sposob wytwarzania nowego peptydu

Info

Publication number
PL211703A1
PL211703A1 PL21170378A PL21170378A PL211703A1 PL 211703 A1 PL211703 A1 PL 211703A1 PL 21170378 A PL21170378 A PL 21170378A PL 21170378 A PL21170378 A PL 21170378A PL 211703 A1 PL211703 A1 PL 211703A1
Authority
PL
Poland
Prior art keywords
making
new peptide
peptide
new
Prior art date
Application number
PL21170378A
Other languages
English (en)
Other versions
PL114981B1 (en
Original Assignee
Reckitt & Colmann Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt & Colmann Prod Ltd filed Critical Reckitt & Colmann Prod Ltd
Publication of PL211703A1 publication Critical patent/PL211703A1/pl
Publication of PL114981B1 publication Critical patent/PL114981B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/70Enkephalins
    • C07K14/702Enkephalins with at least 1 amino acid in D-form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/06Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
    • C07C275/14Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1016Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL1978211703A 1977-12-15 1978-12-13 Process for preparing novel peptide PL114981B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB5223777 1977-12-15
GB1384578 1978-04-08

Publications (2)

Publication Number Publication Date
PL211703A1 true PL211703A1 (pl) 1979-08-13
PL114981B1 PL114981B1 (en) 1981-03-31

Family

ID=26250049

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1978211703A PL114981B1 (en) 1977-12-15 1978-12-13 Process for preparing novel peptide

Country Status (25)

Country Link
US (1) US4178371A (pl)
JP (1) JPS5490142A (pl)
AT (1) AT363198B (pl)
AU (1) AU523732B2 (pl)
CA (1) CA1145330A (pl)
CH (1) CH638177A5 (pl)
CS (1) CS210679B2 (pl)
DD (1) DD140562A5 (pl)
DE (1) DE2854105A1 (pl)
DK (1) DK540678A (pl)
ES (1) ES475997A1 (pl)
FI (1) FI783751A (pl)
FR (1) FR2411829A1 (pl)
GR (1) GR72716B (pl)
IE (1) IE47764B1 (pl)
IL (1) IL56181A (pl)
IT (1) IT7869853A0 (pl)
LU (1) LU80654A1 (pl)
NL (1) NL7812166A (pl)
NZ (1) NZ189047A (pl)
PL (1) PL114981B1 (pl)
PT (1) PT68900A (pl)
SE (1) SE7812720L (pl)
SU (1) SU793386A3 (pl)
ZA (1) ZA786966B (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4259234A (en) * 1976-09-27 1981-03-31 Eli Lilly And Company Analgesic compounds
US4322342A (en) * 1977-06-20 1982-03-30 Eli Lilly And Company Analgesic compounds
US4254024A (en) * 1979-10-16 1981-03-03 Pennwalt Corporation Tetrapeptides and derivatives having opiate activity
JPS5692846A (en) * 1979-12-27 1981-07-27 Takeda Chem Ind Ltd Tetrapeptide derivative and its preparation
HU181013B (en) * 1980-01-25 1983-05-30 Gyogyszerkutato Intezet Process for preparing new enkephalin analogues
WO1982000640A1 (fr) * 1980-08-18 1982-03-04 Akita T Derives de tripeptides alkylamide
US4316892A (en) * 1980-11-03 1982-02-23 G. D. Searle & Co. 2,6-C-Dimethyltyrosine1 -D-amino acid2 -ε-amino caproic and γ aminobutyric acid5 derivatives of methionine enkephalin
EP0076557B1 (en) * 1981-06-22 1985-11-13 Imperial Chemical Industries Plc Peptides and pseudopeptides in which the n terminus bears two substituents
US4454120A (en) * 1981-07-24 1984-06-12 Sterling Drug Inc. Analgesic dipeptide amides and method of use and compositions thereof
US4450155A (en) * 1981-07-24 1984-05-22 Sterling Drug Inc. Analgesic dipeptide amides and method of use and compositions thereof
US4533657A (en) * 1981-07-24 1985-08-06 Sterling Drug Inc. Analgesic dipeptide amides and method of use and composition thereof
US4658013A (en) * 1981-07-28 1987-04-14 Sterling Drug Inc. Analgesic and/or opiate antagonist tripeptide amides and processes for preparation and compositions thereof
US4407746A (en) * 1981-12-14 1983-10-04 G. D. Searle & Co. Cyclohexyl and phenyl substituted enkephalins
NZ203187A (en) * 1982-02-05 1986-05-09 Wellcome Found Peptide derivatives and pharmaceutical compositions
US4430327A (en) 1982-05-18 1984-02-07 Eli Lilly And Company Method for treating pregnant females for pain and anxiety
GB8314646D0 (en) * 1983-05-26 1983-06-29 Wellcome Found Pharmaceutical amides
US4603121A (en) * 1983-10-06 1986-07-29 G. D. Searle & Co. Enkephalin analogs
US4495178A (en) * 1983-10-06 1985-01-22 G. D. Searle & Co. Enkephalin analogs
CA2215211A1 (en) * 1995-03-31 1996-10-03 Takeda Chemical Industries, Ltd. Cysteine protease inhibitor
FR2788518B1 (fr) * 1999-01-14 2001-03-02 Centre Nat Rech Scient Nouveaux carbamates actives stables, leur procede de preparation et leur utilisation pour la preparation d'urees
US7777030B2 (en) 2005-12-29 2010-08-17 Centre National de la Recherge Scientifique (CNRS) Compositions and methods for the treatment and prevention of disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI770219A (pl) * 1976-02-02 1977-08-03 Sandoz Ag
NZ183712A (en) * 1976-04-08 1979-10-25 Ici Ltd Polypeptide analogues of enkephalins, and pharmaceutical compositions

Also Published As

Publication number Publication date
US4178371A (en) 1979-12-11
AU523732B2 (en) 1982-08-12
GR72716B (pl) 1983-12-01
DD140562A5 (de) 1980-03-12
SU793386A3 (ru) 1980-12-30
PL114981B1 (en) 1981-03-31
NL7812166A (nl) 1979-06-19
LU80654A1 (fr) 1980-07-21
AU4219978A (en) 1979-06-21
JPS5490142A (en) 1979-07-17
FI783751A (fi) 1979-06-16
IL56181A (en) 1982-05-31
NZ189047A (en) 1981-12-15
IE47764B1 (en) 1984-06-13
ZA786966B (en) 1980-11-26
CA1145330A (en) 1983-04-26
AT363198B (de) 1981-07-10
PT68900A (en) 1979-01-01
IT7869853A0 (it) 1978-12-14
FR2411829A1 (fr) 1979-07-13
FR2411829B1 (pl) 1983-11-18
ATA899878A (de) 1980-12-15
SE7812720L (sv) 1979-06-16
DK540678A (da) 1979-07-06
ES475997A1 (es) 1979-11-01
CS210679B2 (en) 1982-01-29
DE2854105A1 (de) 1979-06-21
IL56181A0 (en) 1979-03-12
IE782475L (en) 1979-06-15
CH638177A5 (fr) 1983-09-15

Similar Documents

Publication Publication Date Title
PL211753A1 (pl) Sposob wytwarzania nowych 1,1-dwuoksydo-4-hydroksy-2h-1,2-benzotiazyno-3-karboksyamidow
PL211703A1 (pl) Sposob wytwarzania nowego peptydu
PL201286A1 (pl) Sposob wytwarzania nowych 1-aryloksy-2-hydroksy-3-alkileno-aminopropanow
PL205287A1 (pl) Sposob wytwarzania nowych 4-acyloaminofenylo-etanoloamin
PL211164A1 (pl) Sposob wytwarzania nowych peptydow
PL207766A1 (pl) Sposob wytwarzania nowych pochodnych peptydowych
PL202305A1 (pl) Sposob wytwarzania furanokumaryny
PL208497A1 (pl) Sposob wytwarzania peptydow
PL199942A1 (pl) Sposob wytwarzania nowych pierscieniowych szesciopeptydow
PL200534A1 (pl) Sposob wytwarzania nowych oksadeztiacefalosporyn
PL208496A1 (pl) Sposob wytwarzania nowych peptydow
PL208543A1 (pl) Sposob wytwarzania nowych imidazoizochinolinodionow
PL207592A1 (pl) Sposob wytwarzania nowych pirydazynylohydrazonow
PL104866B1 (pl) Sposob wytwarzania nowych pirydobenzodwuazepinonow
PL205285A1 (pl) Sposob wytwarzania nowych laktamow
PL200570A1 (pl) Sposob wytwarzania nowych aryloalkiloamin
PL211668A1 (pl) Sposob wytwarzania nowych 3-dwu-n-propyloacetoksybenzodiazepinonow-2
PL205590A1 (pl) Sposob wytwarzania 2-hydroksybenzotiazoli
PL204964A1 (pl) Sposob wytwarzania akantomycyny
PL198559A1 (pl) Sposob wytwarzania dwu-n-propylo-acetonitrylu
PL204882A1 (pl) Sposob wytwarzania nowych triazolo-tieno-dwuazepinonow-1
PL199670A1 (pl) Sposob wytwarzania dwuaminoalkoksybenzenow
PL208342A1 (pl) Sposob wytwarzania nowych antybiotykow
PL196842A1 (pl) Sposob wytwarzania nowych zasadowych barwnikow metinowych
PL200552A1 (pl) Sposob otrzymywania kandeliny